Where no synapses go: Gatekeepers of circuit remodeling and synaptic strength

Trends in Neurosciences

Volumn 36, Issue 6, 2013, Pages 363-373

  Mironova, Yevgeniya A ^a   Giger, Roman J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Dendritic spine; Nogo receptor; Nogo A; Oligodendrocyte myelin glycoprotein (OMgp); Proteoglycan; Synapse stability; Synaptic structure

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BETA1 INTEGRIN; BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; GLUTAMATE DECARBOXYLASE 67; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN NOGO A; PROTEOCHONDROITIN SULFATE; SULFATIDE;

CENTRAL NERVOUS SYSTEM; DENDRITIC SPINE; ELECTRIC ACTIVITY; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETIC MANIPULATION; HUMAN; INTRACELLULAR SIGNALING; LONG TERM MEMORY; LONG TERM POTENTIATION; MATURATION; MENTAL DISEASE; MOLECULAR INTERACTION; NERVE CELL; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVOUS SYSTEM FUNCTION; NEURITE; NEUROTRANSMISSION; NONHUMAN; POST TETANIC POTENTIATION; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RETINA GANGLION CELL; REVIEW; STRIATE CORTEX; SYNAPSE; SYNAPTIC EFFICACY; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS;

AMNESIA; ANIMALS; ASTROCYTES; BRAIN; BRAIN INJURIES; CHONDROITIN SULFATE PROTEOGLYCANS; CYTOSKELETON; DENDRITES; DOMINANCE, OCULAR; GLYCOSAMINOGLYCANS; GPI-LINKED PROTEINS; HUMANS; MENTAL DISORDERS; MICE; MODELS, NEUROLOGICAL; MYELIN PROTEINS; NERVE REGENERATION; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES; SYNAPSES;

EID: 84878535927     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2013.04.003     Document Type: Review

References (111)

1. Holtmaat A., Svoboda K. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci. 2009, 10:647-658.
2. Florence S.L., et al. Large-scale sprouting of cortical connections after peripheral injury in adult macaque monkeys. Science 1998, 282:1117-1121.
3. Bareyre F.M., et al. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat. Neurosci. 2004, 7:269-277.
4. Giger R.J., et al. Guidance molecules in axon regeneration. Cold Spring Harb. Perspect. Biol. 2010, 2:a001867.
5. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
6. Garcia-Alias G., Fawcett J.W. Training and anti-CSPG combination therapy for spinal cord injury. Exp. Neurol. 2012, 235:26-32.
7. Imagama S., et al. Keratan sulfate restricts neural plasticity after spinal cord injury. J. Neurosci. 2011, 31:17091-17102.
8. Winzeler A.M., et al. The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth. J. Neurosci. 2011, 31:6481-6492.
9. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 2006, 7:617-627.
10. Li S., et al. Blockade of Nogo66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo66 receptor promotes axonal sprouting and recovery after spinal injury. J. Neurosci. 2004, 24:10511-10520.
11. Zorner B., Schwab M.E. Anti-Nogo on the go: from animal models to a clinical trial. Ann. N. Y. Acad. Sci. 2010, 1198(Suppl. 1):E22-E34.
12. Cafferty W.B., et al. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J. Neurosci. 2010, 30:6825-6837.
13. Lee J.K., et al. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 2010, 66:663-670.
14. Lee J.K., Zheng B. Role of myelin-associated inhibitors in axonal repair after spinal cord injury. Exp. Neurol. 2012, 235:33-42.
15. Chivatakarn O., et al. The Nogo66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors. J. Neurosci. 2007, 27:7117-7124.
16. Atwal J.K., et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 2008, 322:967-970.
17. Zheng B., et al. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1205-1210.
18. Kim J.E., et al. Nogo66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 2004, 44:439-451.
19. Shen Y., et al. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326:592-596.
20. Fisher D., et al. Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J. Neurosci. 2011, 31:14051-14066.
21. Brown J.M., et al. A sulfated carbohydrate epitope inhibits axon regeneration after injury. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:4768-4773.
22. Dickendesher T.L., et al. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat. Neurosci. 2012, 15:703-712.
23. Gilbert R.J., et al. CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol. Cell. Neurosci. 2005, 29:545-558.
24. Venkatesh K., et al. The Nogo66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J. Neurosci. 2005, 25:808-822.
25. Stiles T.L., et al. LDL receptor-related protein-1 is a sialic acid-independent receptor for myelin-associated glycoprotein (MAG) that functions in neurite outgrowth inhibition by MAG and CNS myelin. J. Cell Sci. 2013, 126:209-220.
26. Vyas A.A., et al. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8412-8417.
27. Goh E.L., et al. β1-Integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones. Mol. Brain 2008, 1:10.
28. Morishita H., Hensch T.K. Critical period revisited: impact on vision. Curr. Opin. Neurobiol. 2008, 18:101-107.
29. McGee A.W., et al. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 2005, 309:2222-2226.
30. Datwani A., et al. Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. Neuron 2009, 64:463-470.
31. Syken J., et al. PirB restricts ocular-dominance plasticity in visual cortex. Science 2006, 313:1795-1800.
32. Pizzorusso T., et al. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
33. Pizzorusso T., et al. Structural and functional recovery from early monocular deprivation in adult rats. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8517-8522.
34. Miyata S., et al. Persistent cortical plasticity by upregulation of chondroitin 6-sulfation. Nat. Neurosci. 2012, 15:414-422.
35. Carulli D., et al. Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain 2010, 133:2331-2347.
36. Beurdeley M., et al. Otx2 binding to perineuronal nets persistently regulates plasticity in the mature visual cortex. J. Neurosci. 2012, 32:9429-9437.
37. Sugiyama S., et al. Experience-dependent transfer of Otx2 homeoprotein into the visual cortex activates postnatal plasticity. Cell 2008, 134:508-520.
38. Raiker S.J., et al. Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity. J. Neurosci. 2010, 30:12432-12445.
39. Grunewald E., et al. GPR50 interacts with neuronal NOGO-A and affects neurite outgrowth. Mol. Cell. Neurosci. 2009, 42:363-371.
40. Dityatev A., et al. The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat. Rev. Neurosci. 2010, 11:735-746.
41. Wang X., et al. Localization of Nogo-A and Nogo66 receptor proteins at sites of axon-myelin and synaptic contact. J. Neurosci. 2002, 22:5505-5515.
42. Lee H., et al. Synaptic function for the Nogo66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. J. Neurosci. 2008, 28:2753-2765.
43. Dunah A.W., et al. LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses. Nat. Neurosci. 2005, 8:458-467.
44. Johnson K.G., et al. The HSPGs syndecan and dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic development. Neuron 2006, 49:517-531.
45. Takahashi H., et al. Postsynaptic TrkC and presynaptic PTPσ function as a bidirectional excitatory synaptic organizing complex. Neuron 2011, 69:287-303.
46. Yoshida T., et al. IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase delta. J. Neurosci. 2011, 31:13485-13499.
47. May P., et al. Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol. Cell. Biol. 2004, 24:8872-8883.
48. McGeachie A.B., et al. Stabilising influence: integrins in regulation of synaptic plasticity. Neurosci. Res. 2011, 70:24-29.
49. Zagrebelsky M., et al. Nogo-A stabilizes the architecture of hippocampal neurons. J. Neurosci. 2010, 30:13220-13234.
50. Pradhan A.D., et al. Dendritic spine alterations in neocortical pyramidal neurons following postnatal neuronal Nogo-A knockdown. Dev. Neurosci. 2010, 32:313-320.
51. Wills Z.P., et al. The Nogo receptor family restricts synapse number in the developing hippocampus. Neuron 2012, 73:466-481.
52. Orlando C., et al. Perisynaptic chondroitin sulfate proteoglycans restrict structural plasticity in an integrin-dependent manner. J. Neurosci. 2012, 32:18009-18017.
53. 2+/calmodulin-dependent protein kinase II-mediated actin reorganization. J. Neurosci. 2006, 26:1813-1822.
54. Hu F., Strittmatter S.M. The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J. Neurosci. 2008, 28:1262-1269.
55. Tan C.L., et al. Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J. Neurosci. 2011, 31:6289-6295.
56. Zhou F.Q., et al. Neurotrophins support regenerative axon assembly over CSPGs by an ECM-integrin-independent mechanism. J. Cell Sci. 2006, 119:2787-2796.
57. Allen N.J., et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 2012, 486:410-414.
58. Siddiqui T.J., Craig A.M. Synaptic organizing complexes. Curr. Opin. Neurobiol. 2011, 21:132-143.
59. Paradis S., et al. An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development. Neuron 2007, 53:217-232.
60. Tran T.S., et al. Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS. Nature 2009, 462:1065-1069.
61. Sahay A., et al. Secreted semaphorins modulate synaptic transmission in the adult hippocampus. J. Neurosci. 2005, 25:3613-3620.
62. O'Connor T.P., et al. Semaphorin 5B mediates synapse elimination in hippocampal neurons. Neural Dev. 2009, 4:18.
63. De Wit J., et al. Role of leucine-rich repeat proteins in the development and function of neural circuits. Annu. Rev. Cell Dev. Biol. 2011, 27:697-729.
64. Holtmaat A.J., et al. Transient and persistent dendritic spines in the neocortex in vivo. Neuron 2005, 45:279-291.
65. Akbik F.V., et al. Anatomical plasticity of adult brain is titrated by Nogo receptor 1. Neuron 2013, 77:859-866.
66. Ethell I.M., et al. EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron 2001, 31:1001-1013.
67. Kaufmann N., et al. Drosophila liprin-alpha and the receptor phosphatase Dlar control synapse morphogenesis. Neuron 2002, 34:27-38.
68. Kaksonen M., et al. Syndecan-3-deficient mice exhibit enhanced LTP and impaired hippocampus-dependent memory. Mol. Cell. Neurosci. 2002, 21:158-172.
69. Brakebusch C., et al. Brevican-deficient mice display impaired hippocampal CA1 long-term potentiation but show no obvious deficits in learning and memory. Mol. Cell. Biol. 2002, 22:7417-7427.
70. Kantor D.B., et al. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 2004, 44:961-975.
71. Coles C.H., et al. Proteoglycan-specific molecular switch for RPTPsigma clustering and neuronal extension. Science 2011, 332:484-488.
72. Inatani M., et al. Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science 2003, 302:1044-1046.
73. Cho J.Y., et al. The extracellular matrix proteoglycan perlecan facilitates transmembrane semaphorin-mediated repulsive guidance. Genes Dev. 2012, 26:2222-2235.
74. Pyka M., et al. Chondroitin sulfate proteoglycans regulate astrocyte-dependent synaptogenesis and modulate synaptic activity in primary embryonic hippocampal neurons. Eur. J. Neurosci. 2011, 33:2187-2202.
75. Li A.J., et al. Fibroblast growth factor-2 increases functional excitatory synapses on hippocampal neurons. Eur. J. Neurosci. 2002, 16:1313-1324.
76. Delekate A., et al. NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2569-2574.
77. Joset A., et al. Pincher-generated Nogo-A endosomes mediate growth cone collapse and retrograde signaling. J. Cell Biol. 2010, 188:271-285.
78. Peng X., et al. Neuronal Nogo-A regulates glutamate receptor subunit expression in hippocampal neurons. J. Neurochem. 2011, 119:1183-1193.
79. Horn K.E., et al. Receptor protein tyrosine phosphatase sigma regulates synapse structure, function and plasticity. J. Neurochem. 2012, 122:147-161.
80. Brenneke F., et al. Mice deficient for the extracellular matrix glycoprotein tenascin-r show physiological and structural hallmarks of increased hippocampal excitability, but no increased susceptibility to seizures in the pilocarpine model of epilepsy. Neuroscience 2004, 124:841-855.
81. Frischknecht R., et al. Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity. Nat. Neurosci. 2009, 12:897-904.
82. Gao Y., et al. Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo. Neuron 2004, 44:609-621.
83. Gao Y., et al. Neurotrophins elevate cAMP to reach a threshold required to overcome inhibition by MAG through extracellular signal-regulated kinase-dependent inhibition of phosphodiesterase. J. Neurosci. 2003, 23:11770-11777.
84. Deng K., et al. Overcoming amino-Nogo-induced inhibition of cell spreading and neurite outgrowth by 12-O-tetradecanoylphorbol-13-acetate-type tumor promoters. J. Biol. Chem. 2010, 285:6425-6433.
85. Kurihara D., Yamashita T. Chondroitin sulfate proteoglycans down-regulate spine formation in cortical neurons by targeting tropomyosin-related kinase B (TrkB) protein. J. Biol. Chem. 2012, 287:13822-13828.
86. Kelleher R.J., et al. Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron 2004, 44:59-73.
87. Fortin D.A., et al. Brain-derived neurotrophic factor activation of CaM-kinase kinase via transient receptor potential canonical channels induces the translation and synaptic incorporation of GluA1-containing calcium-permeable AMPA receptors. J. Neurosci. 2012, 32:8127-8137.
88. Fukata Y., et al. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 2006, 313:1792-1795.
89. Thomas R., et al. LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition. J. Neurosci. 2010, 30:6607-6612.
90. Walmsley A.R., et al. Zinc metalloproteinase-mediated cleavage of the human Nogo66 receptor. J. Cell Sci. 2004, 117:4591-4602.
91. Ferraro G.B., et al. Membrane-type matrix metalloproteinase-3 regulates neuronal responsiveness to myelin through Nogo66 receptor 1 cleavage. J. Biol. Chem. 2011, 286:31418-31424.
92. Josephson A., et al. Activity-induced and developmental downregulation of the Nogo receptor. Cell Tissue Res. 2003, 311:333-342.
93. Chytrova G., et al. Exercise normalizes levels of MAG and Nogo-A growth inhibitors after brain trauma. Eur. J. Neurosci. 2008, 27:1-11.
94. Griesbach G.S., et al. Exercise-induced improvement in cognitive performance after traumatic brain injury in rats is dependent on BDNF activation. Brain Res. 2009, 1288:105-115.
95. Gomez-Pinilla F., et al. Physical exercise induces FGF-2 and its mRNA in the hippocampus. Brain Res. 1997, 764:1-8.
96. Garcia-Alias G., et al. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat. Neurosci. 2009, 12:1145-1151.
97. Van Gaalen M.M., et al. NOGO66 receptor deficient mice show slow acquisition of spatial memory task performance. Neurosci. Lett. 2012, 510:58-61.
98. Karlen A., et al. Nogo receptor 1 regulates formation of lasting memories. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20476-20481.
99. Gogolla N., et al. Perineuronal nets protect fear memories from erasure. Science 2009, 325:1258-1261.
100. Budel S., et al. Genetic variants of Nogo66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J. Neurosci. 2008, 28:13161-13172.
101. Willi R., Schwab M.E. Nogo and Nogo receptor: relevance to schizophrenia?. Neurobiol. Dis. 2013, 10.1016/j.nbd.2013.01.011.
102. Wang H., et al. Chondroitin-4-sulfation negatively regulates axonal guidance and growth. J. Cell Sci. 2008, 121:3083-3091.
103. Bartolini B., et al. Mouse development is not obviously affected by the absence of dermatan sulfate epimerase 2 in spite of a modified brain dermatan sulfate composition. Glycobiology 2012, 22:1007-1016.
104. Li H.P., et al. Roles of chondroitin sulfate and dermatan sulfate in the formation of a lesion scar and axonal regeneration after traumatic injury of the mouse brain. J. Neurotrauma 2013, 30:413-425.
105. Williams G., et al. Ganglioside inhibition of neurite outgrowth requires Nogo receptor function: identification of interaction sites and development of novel antagonists. J. Biol. Chem. 2008, 283:16641-16652.
106. Park J.H., et al. Alzheimer precursor protein interaction with the Nogo66 receptor reduces amyloid-beta plaque deposition. J. Neurosci. 2006, 26:1386-1395.
107. Zhang L., et al. Identification of BLyS (B lymphocyte stimulator), a non-myelin-associated protein, as a functional ligand for Nogo66 receptor. J. Neurosci. 2009, 29:6348-6352.
108. Sato Y., et al. Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation. Science 2011, 333:769-773.
109. Nakaya N., et al. Olfactomedin 1 interacts with the Nogo A receptor complex to regulate axon growth. J. Biol. Chem. 2012, 287:37171-37184.
110. Zhou X., et al. Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition. FASEB J. 2011, 25:3146-3156.
111. Tews B., et al. Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function. Proc Natl Acad Sci U S A 2013, 110:6583-6588.